Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Pediatr. 2019 Sep 24;215:107–117.e12. doi: 10.1016/j.jpeds.2019.07.064

Figure 2.

Figure 2.

Levels of 24(S)-hydroxycholesterol with and without atorvastatin therapy and across dose levels. (A) 24(S)-hydroxycholesterol levels after 6 weeks of KD diagnosis is shown in KD subjects who received IVIG and infliximab versus IVIG, infliximab and atorvastatin. (B) The individual 24(S) hydroxycholesterol level for each KD subject treated with atorvastatin is shown by dose level. Red: 0.25 mg/kg, Green: 0.5 mg/kg, Purple: 0.75 mg/kg, Black: without atorvastatin treatment.